MD Stock - Pediatrix Medical Group, Inc.
Unlock GoAI Insights for MD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.01B | $1.99B | $1.97B | $1.91B | $1.73B |
| Gross Profit | $454.34M | $421.56M | $467.03M | $513.24M | $449.32M |
| Gross Margin | 22.6% | 21.1% | 23.7% | 26.9% | 25.9% |
| Operating Income | $-68,713,000 | $7.32M | $172.69M | $202.92M | $98.13M |
| Net Income | $-99,069,000 | $-60,408,000 | $66.33M | $130.96M | $-796,488,000 |
| Net Margin | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% |
| EPS | $-1.19 | $-0.72 | $0.80 | $1.52 | $-9.31 |
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2024 | Macquarie | Initiation | Outperform | - |
| September 26th 2024 | Jefferies | Upgrade | Buy | $14← $8 |
| June 7th 2024 | Deutsche Bank | Upgrade | Hold | $8 |
Earnings History & Surprises
MDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 19, 2026 | $0.53 | — | — | — |
Q4 2025 | Nov 3, 2025 | $0.46 | $0.67 | +45.7% | ✓ BEAT |
Q3 2025 | Aug 5, 2025 | $0.42 | $0.53 | +26.2% | ✓ BEAT |
Q2 2025 | May 6, 2025 | $0.25 | $0.33 | +32.0% | ✓ BEAT |
Q1 2025 | Feb 20, 2025 | $0.37 | $0.51 | +37.8% | ✓ BEAT |
Q4 2024 | Nov 1, 2024 | $0.37 | $0.44 | +18.9% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $0.31 | $0.34 | +9.7% | ✓ BEAT |
Q2 2024 | May 7, 2024 | $0.18 | $0.20 | +11.1% | ✓ BEAT |
Q1 2024 | Feb 20, 2024 | $0.32 | $0.32 | 0.0% | = MET |
Q4 2023 | Nov 2, 2023 | $0.43 | $0.32 | -25.6% | ✗ MISS |
Q3 2023 | Aug 3, 2023 | $0.40 | $0.39 | -2.5% | ✗ MISS |
Q2 2023 | May 2, 2023 | $0.22 | $0.23 | +4.5% | ✓ BEAT |
Q1 2023 | Feb 17, 2023 | $0.49 | $0.47 | -4.1% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $0.55 | $0.40 | -27.3% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $0.47 | $0.47 | 0.0% | = MET |
Q2 2022 | Apr 28, 2022 | $0.27 | $0.33 | +22.2% | ✓ BEAT |
Q1 2022 | Feb 17, 2022 | $0.44 | $0.52 | +18.2% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $0.42 | $0.46 | +9.5% | ✓ BEAT |
Q3 2021 | Aug 6, 2021 | $0.32 | $0.41 | +28.1% | ✓ BEAT |
Latest News
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $24
➖ NeutralUBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23
➖ NeutralPediatrix Medical Group shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositivePediatrix Medical Group Q3 Adj. EPS $0.67 Beats $0.47 Estimate, Sales $492.875M Beat $476.493M Estimate
📈 PositiveLeerink Partners Maintains Market Perform on Pediatrix Medical Group, Raises Price Target to $17
➖ NeutralPediatrix Medical Group Authorizes $250M Share Repurchase Program
📈 PositiveFrequently Asked Questions about MD
What is MD's current stock price?
What is the analyst price target for MD?
What sector is Pediatrix Medical Group, Inc. in?
What is MD's market cap?
Does MD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MD for comparison